Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.42
-0.14 (-0.43%)
Nov 20, 2024, 4:00 PM EST - Market closed
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 296.31 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
| Revenue | 296.31 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
| Revenue Growth (YoY) | 25.09% | 43.05% | 377.91% | 21.15% | 17.32% | 8.52% | Upgrade
|
| Cost of Revenue | 208.75 | 164.58 | 103.01 | 100.25 | 74.81 | 99.99 | Upgrade
|
| Gross Profit | 87.56 | 84.85 | 71.35 | -63.76 | -44.7 | -74.32 | Upgrade
|
| Selling, General & Admin | 154.91 | 144.5 | 123.06 | 110.82 | 45.74 | 44.18 | Upgrade
|
| Research & Development | 0.72 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | 0.9 | 0.9 | -0.01 | 0.07 | -1.61 | -0.19 | Upgrade
|
| Operating Expenses | 156.52 | 145.39 | 123.05 | 110.9 | 44.13 | 44 | Upgrade
|
| Operating Income | -68.96 | -60.55 | -51.7 | -174.66 | -88.83 | -118.32 | Upgrade
|
| Interest Expense | -13.12 | -5.15 | -5.41 | -5.57 | -3.11 | -3.8 | Upgrade
|
| Interest & Investment Income | 25.89 | 17.99 | 3.76 | 0.07 | 0.71 | 1.4 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.48 | -13.18 | 14.16 | 0.29 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 13.91 | - | - | - | 1.24 | -5.47 | Upgrade
|
| EBT Excluding Unusual Items | -53.76 | -60.89 | -39.2 | -179.88 | -90 | -126.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -1.06 | - | Upgrade
|
| Other Unusual Items | - | - | -1.69 | - | 3.7 | - | Upgrade
|
| Pretax Income | -53.76 | -60.89 | -40.88 | -179.88 | -87.36 | -126.19 | Upgrade
|
| Income Tax Expense | -6.71 | -5.6 | 11.66 | 0.15 | -13.27 | -22.26 | Upgrade
|
| Net Income | -47.05 | -55.29 | -52.54 | -180.03 | -74.09 | -103.93 | Upgrade
|
| Net Income to Common | -47.05 | -55.29 | -52.54 | -180.03 | -74.09 | -103.93 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 46 | 42 | 27 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 49 | 46 | 42 | 27 | 22 | Upgrade
|
| Shares Change (YoY) | 2.79% | 6.94% | 7.59% | 60.19% | 18.95% | 3.43% | Upgrade
|
| EPS (Basic) | -0.94 | -1.13 | -1.15 | -4.24 | -2.79 | -4.66 | Upgrade
|
| EPS (Diluted) | -0.95 | -1.13 | -1.15 | -4.24 | -2.79 | -4.66 | Upgrade
|
| Free Cash Flow | 19.87 | -2.49 | -51.41 | -144.49 | -64.32 | -106.98 | Upgrade
|
| Free Cash Flow Per Share | 0.40 | -0.05 | -1.12 | -3.40 | -2.43 | -4.80 | Upgrade
|
| Gross Margin | 29.55% | 34.02% | 40.92% | -174.77% | -148.42% | -289.54% | Upgrade
|
| Operating Margin | -23.27% | -24.27% | -29.65% | -478.73% | -294.98% | -460.95% | Upgrade
|
| Profit Margin | -15.88% | -22.17% | -30.13% | -493.45% | -246.04% | -404.89% | Upgrade
|
| Free Cash Flow Margin | 6.71% | -1.00% | -29.49% | -396.04% | -213.60% | -416.76% | Upgrade
|
| EBITDA | -64.89 | -56.46 | -46.37 | -167.07 | -82.38 | -111.56 | Upgrade
|
| EBITDA Margin | -21.90% | -22.63% | -26.59% | - | -273.57% | - | Upgrade
|
| D&A For EBITDA | 4.07 | 4.09 | 5.34 | 7.59 | 6.45 | 6.76 | Upgrade
|
| EBIT | -68.96 | -60.55 | -51.7 | -174.66 | -88.83 | -118.32 | Upgrade
|
| EBIT Margin | -23.27% | -24.27% | -29.65% | - | -294.98% | - | Upgrade
|
| Revenue as Reported | 296.31 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.